DRUG CLASS in iGMDR
Antiparasitic Products, Insecticides and Repellents
iGMDRD39Cytochrome P-450 CYP2C19 Substrates
iGMDRD18Cytochrome P-450 CYP2B6 Inhibitors (moderate)
iGMDRD202Cytochrome P-450 CYP3A4 Inducers (weak)
iGMDRD68Anti-Acne Preparations for Topical Use
iGMDRD48Sympathomimetic (Adrenergic) Agents
iGMDRD53Protein Kinase C, antagonists & inhibitors
iGMDRD354Epithelial Sodium Channel Blockers
iGMDRD59Cytochrome P-450 CYP2C8 Inhibitors (weak)
iGMDRD381Drugs for Acid Related Disorders
iGMDRD17Ribonucleotide Reductases, antagonists & inhibitors
iGMDRD79Vascular Endothelial Growth Factor Receptor-2, antagonists & inhibitors
iGMDRD417Cytochrome P-450 CYP2C19 Inhibitors (weak)
iGMDRD381p21-Activated Kinases, antagonists & inhibitors
iGMDRD591Class I Phosphatidylinositol 3-Kinases, antagonists & inhibitors
iGMDRD671Methemoglobinemia Associated Agents
iGMDRD22Receptor, PAR-1, antagonists & inhibitors
iGMDRD393Alpha-and Beta-adrenergic Agonists
iGMDRD53Dopamine D2 Receptor Antagonists
iGMDRD38Receptor, Fibroblast Growth Factor, Type 1, antagonists & inhibitors
iGMDRD691Vaginal Creams, Foams, and Jellies
iGMDRD16Cytochrome P-450 CYP2C9 Inducers (weak)
iGMDRD555Agents Acting on the Renin-Angiotensin System
iGMDRD25Combined Inhibitors of Serotonin/Norepinephrine Reuptake
iGMDRD53Antiinflammatory and Antirheumatic Products, Non-Steroids
iGMDRD107Cytochrome P-450 CYP2D6 Inhibitors (strong)
iGMDRD354Angiotensin II Antagonists, Plain
iGMDRD25Adrenergic alpha-1 Receptor Agonists
iGMDRD53Sex Hormones and Modulators of the Genital System
iGMDRD58Cytochrome P-450 CYP3A7 Inhibitors (moderate)
iGMDRD17Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)
iGMDRD17Receptors, Vascular Endothelial Growth Factor
iGMDRD134Janus Kinase 2, antagonists & inhibitors
iGMDRD502Cytochrome P-450 CYP3A5 Inhibitors
iGMDRD17Cytochrome P-450 CYP3A5 Inhibitors (strong)
iGMDRD77Cytochrome P-450 CYP2E1 Inhibitors (strong)
iGMDRD354Phenothiazines With Piperazine Structure
iGMDRD38Class Ia Phosphatidylinositol 3-Kinase, antagonists & inhibitors
iGMDRD455Topical Products for Joint and Muscular Pain
iGMDRD207Nasal Decongestants for Systemic Use
iGMDRD53Protein-Serine-Threonine Kinases, antagonists & inhibitors
iGMDRD314Angiotensin II Antagonists and Calcium Channel Blockers
iGMDRD25Cytochrome P-450 CYP2C19 Inducers (strong)
iGMDRD555Calcium-Calmodulin-Dependent Protein Kinases
iGMDRD324Urokinase-Type Plasminogen Activator, antagonists & inhibitors
iGMDRD87Drugs for Obstructive Airway Diseases
iGMDRD171Detoxifying Agents for Antineoplastic Treatment
iGMDRD122Corticosteroids, Moderately Potent (Group II)
iGMDRD48Cytochrome P-450 CYP1A2 Inducers (moderate)
iGMDRD381Isocitrate Dehydrogenase 2 Inhibitor
iGMDRD790Cytochrome P-450 CYP2A6 Inhibitors
iGMDRD28Cytochrome P-450 CYP2A6 Inhibitors (strong)
iGMDRD28Cytochrome P-450 CYP1A2 Inhibitors (weak)
iGMDRD17Cytochrome P-450 CYP3A7 Inhibitors (strong)
iGMDRD77Protease-activated Receptor-1 Antagonist
iGMDRD393Cytochrome P-450 CYP3A5 Inhibitors (moderate)
iGMDRD17Combination Contraceptives (with Estrogen and derivatives)
iGMDRD58Leukemia, Myelogenous, Chronic, BCR-ABL Positive
iGMDRD145Receptor, EphB4, antagonists & inhibitors
iGMDRD417Proto-Oncogene Proteins c-met, antagonists & inhibitors
iGMDRD444Drugs Used in Erectile Dysfunction
iGMDRD40Thymidylate Synthase, antagonists & inhibitors
iGMDRD102Proto-Oncogene Proteins B-raf, antagonists & inhibitors
iGMDRD614Anti-inflammatory Agents, Miscellaneous
iGMDRD270Angiotensin II Antagonists and Diuretics
iGMDRD25Corticosteroids for Systemic Use
iGMDRD48Angiotensin II Type 1 Receptor Blockers
iGMDRD25Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use
iGMDRD48Receptor, Platelet-Derived Growth Factor beta, antagonists & inhibitors
iGMDRD413Other Miscellaneous Therapeutic Agents
iGMDRD58Dihydrofolate Reductase Inhibitor Antimalarial
iGMDRD39HSP90 Heat-Shock Proteins, antagonists & inhibitors
iGMDRD314Cytochrome P-450 CYP3A7 Inhibitors
iGMDRD17Corticosteroids, Dermatological Preparations
iGMDRD48Adrenergic alpha-2 Receptor Agonists
iGMDRD53Corticosteroids for Systemic Use, Plain
iGMDRD48Metalloendopeptidases, antagonists & inhibitors
iGMDRD294Antipsychotic Agents (First Generation [Typical])
iGMDRD38Janus Kinases, antagonists & inhibitors
iGMDRD574Cytochrome P-450 CYP2C8 Substrates
iGMDRD68Receptor, Platelet-Derived Growth Factor alpha, antagonists & inhibitors
iGMDRD413Corticosteroids for Local Oral Treatment
iGMDRD48Cytochrome P-450 CYP2B6 Substrates
iGMDRD18Receptors, Thrombin, antagonists & inhibitors
iGMDRD393DNA Modification Methylases, antagonists & inhibitors
iGMDRD176Selective Cyclooxygenase 2 Inhibitors (NSAIDs)
iGMDRD107Acid Sensing Ion Channel Blockers
iGMDRD59Angiotensin Receptor Antagonists
iGMDRD25Antifungals for Dermatological Use
iGMDRD16Ophthalmological and Otological Preparations
iGMDRD48Agents for Dermatitis, Excluding Corticosteroids
iGMDRD169